DK3359170T3 - Fremgangsmåder til behandling af nuklear faktor kappa-letkæde-enhancer af aktiveret b-celle-(nf-kb)-dysregulering hos en vært med behov derfor ved hjælp af æggeskalsmembransammensætninger - Google Patents
Fremgangsmåder til behandling af nuklear faktor kappa-letkæde-enhancer af aktiveret b-celle-(nf-kb)-dysregulering hos en vært med behov derfor ved hjælp af æggeskalsmembransammensætninger Download PDFInfo
- Publication number
- DK3359170T3 DK3359170T3 DK15905957.5T DK15905957T DK3359170T3 DK 3359170 T3 DK3359170 T3 DK 3359170T3 DK 15905957 T DK15905957 T DK 15905957T DK 3359170 T3 DK3359170 T3 DK 3359170T3
- Authority
- DK
- Denmark
- Prior art keywords
- dyse
- host
- regulation
- activated
- cell
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2015/054742 WO2017062016A1 (en) | 2015-10-08 | 2015-10-08 | METHODS FOR TREATING NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELL (NF-ĸB) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3359170T3 true DK3359170T3 (da) | 2022-10-10 |
Family
ID=58488181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15905957.5T DK3359170T3 (da) | 2015-10-08 | 2015-10-08 | Fremgangsmåder til behandling af nuklear faktor kappa-letkæde-enhancer af aktiveret b-celle-(nf-kb)-dysregulering hos en vært med behov derfor ved hjælp af æggeskalsmembransammensætninger |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10328104B2 (da) |
| EP (1) | EP3359170B1 (da) |
| JP (1) | JP2018531212A (da) |
| KR (1) | KR20180063091A (da) |
| CN (1) | CN107206029A (da) |
| AU (1) | AU2015411324B2 (da) |
| BR (1) | BR112017014304A2 (da) |
| CA (1) | CA2970101A1 (da) |
| DK (1) | DK3359170T3 (da) |
| ES (1) | ES2927890T3 (da) |
| HU (1) | HUE060219T2 (da) |
| MX (1) | MX2017007130A (da) |
| PL (1) | PL3359170T3 (da) |
| RS (1) | RS63620B1 (da) |
| RU (1) | RU2713656C2 (da) |
| WO (1) | WO2017062016A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108991521A (zh) * | 2018-08-10 | 2018-12-14 | 西北农林科技大学 | 一种肠道保护剂及其应用 |
| KR20210052064A (ko) | 2019-10-31 | 2021-05-10 | 강원대학교산학협력단 | 소나무 껍질 추출물을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
| KR102296347B1 (ko) | 2019-11-27 | 2021-09-01 | 강원대학교산학협력단 | 천연물 복합 추출물을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194732A (en) | 1960-10-03 | 1965-07-13 | Neuhauser Irene | Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor |
| US6410516B1 (en) | 1986-01-09 | 2002-06-25 | President & Fellows Of Harvard College | Nuclear factors associated with transcriptional regulation |
| US6617171B2 (en) * | 1998-02-27 | 2003-09-09 | The General Hospital Corporation | Methods for diagnosing and treating autoimmune disease |
| US8580315B2 (en) * | 2004-03-10 | 2013-11-12 | Esm Technologies, Llc | Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations |
| US8324237B2 (en) * | 2005-05-20 | 2012-12-04 | Smith Charles D | Methods for the treatment and prevention of inflammatory diseases |
| US8211477B2 (en) * | 2007-10-17 | 2012-07-03 | Biova, L.L.C. | Solubilized protein composition obtained from eggshell membrane |
| US20100179103A1 (en) * | 2008-07-21 | 2010-07-15 | Ketan Desai | Curcumin cyclodextrin combination for preventing or treating various diseases |
| JP6056064B2 (ja) * | 2013-11-29 | 2017-01-11 | 国立大学法人 東京大学 | 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物 |
-
2015
- 2015-10-08 DK DK15905957.5T patent/DK3359170T3/da active
- 2015-10-08 CA CA2970101A patent/CA2970101A1/en active Pending
- 2015-10-08 CN CN201580076036.0A patent/CN107206029A/zh active Pending
- 2015-10-08 RU RU2017130716A patent/RU2713656C2/ru active
- 2015-10-08 JP JP2017529084A patent/JP2018531212A/ja active Pending
- 2015-10-08 KR KR1020187008834A patent/KR20180063091A/ko unknown
- 2015-10-08 RS RS20220921A patent/RS63620B1/sr unknown
- 2015-10-08 MX MX2017007130A patent/MX2017007130A/es unknown
- 2015-10-08 ES ES15905957T patent/ES2927890T3/es active Active
- 2015-10-08 AU AU2015411324A patent/AU2015411324B2/en active Active
- 2015-10-08 US US15/528,335 patent/US10328104B2/en active Active
- 2015-10-08 EP EP15905957.5A patent/EP3359170B1/en active Active
- 2015-10-08 BR BR112017014304A patent/BR112017014304A2/pt not_active Application Discontinuation
- 2015-10-08 HU HUE15905957A patent/HUE060219T2/hu unknown
- 2015-10-08 PL PL15905957.5T patent/PL3359170T3/pl unknown
- 2015-10-08 WO PCT/US2015/054742 patent/WO2017062016A1/en active Application Filing
-
2019
- 2019-06-06 US US16/433,683 patent/US11020437B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017014304A2 (pt) | 2018-03-06 |
| AU2015411324B2 (en) | 2023-06-15 |
| EP3359170A1 (en) | 2018-08-15 |
| AU2015411324A1 (en) | 2018-03-22 |
| US11020437B2 (en) | 2021-06-01 |
| RU2017130716A3 (da) | 2019-05-06 |
| EP3359170B1 (en) | 2022-09-21 |
| US20190365824A1 (en) | 2019-12-05 |
| US20180339002A1 (en) | 2018-11-29 |
| JP2018531212A (ja) | 2018-10-25 |
| US10328104B2 (en) | 2019-06-25 |
| RU2017130716A (ru) | 2019-02-28 |
| MX2017007130A (es) | 2018-01-30 |
| RS63620B1 (sr) | 2022-10-31 |
| WO2017062016A1 (en) | 2017-04-13 |
| EP3359170A4 (en) | 2019-05-01 |
| CN107206029A (zh) | 2017-09-26 |
| CA2970101A1 (en) | 2017-04-13 |
| ES2927890T3 (es) | 2022-11-11 |
| RU2713656C2 (ru) | 2020-02-06 |
| HUE060219T2 (hu) | 2023-02-28 |
| PL3359170T3 (pl) | 2022-11-07 |
| KR20180063091A (ko) | 2018-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3298498T3 (da) | Adressevalidering ved brug af signaturer | |
| DK3286311T3 (da) | Fremgangsmåde til behandling af maligniteter | |
| DK3366295T3 (da) | Fremgangsmåder til behandling af filoviridae virusinfektioner | |
| DK3116900T3 (da) | Sammensætninger som kan anvendes til behandling af ornithintranscarbamylase (otc) defekt | |
| DK3185957T3 (da) | Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis | |
| DK3122458T3 (da) | Fremgangsmåde til beklædning af et filtersubstrat | |
| DK3498692T3 (da) | Isoindolin-sammensætninger og fremgangsmåder til behandling af neurodegenerativ sygdom og makulær degeneration | |
| DK3134130T3 (da) | Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3307296T3 (da) | Timp2 til anvendelse til behandling af aldringsassocierede tilstande | |
| DK3244886T3 (da) | Indolderivater som inhibitorer af dengue virus-replikation | |
| DK3127923T3 (da) | Fremgangsmåde til forbedring af oppløselighed af protein og peptid ved hjælp af immunoglobulin-fc-fragment-binding | |
| DK3502316T3 (da) | Fremgangsmåde til cts-overfladekorrosionsbeskyttende behandling af en del af rustfrit stål | |
| DK3393468T3 (da) | Fremgangsmåder til behandling af en immundefektsygdom | |
| DK3165272T3 (da) | Apparatur til behandling af udstødningsgas | |
| DK3456330T3 (da) | Cortexolon-17alpha-valerat til anvendelse ved behandling af tumorer | |
| DK3318115T3 (da) | Maskine til behandling af svinegylle | |
| DK3110446T3 (da) | Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme | |
| DK3122349T3 (da) | Sammensætninger til behandling af autodigestion | |
| DK2921050T3 (da) | Fremgangsmåde til udbringning af plantebeskyttelsesmidler | |
| DK2995637T3 (da) | Coating-sammensætning til træoverfladebehandling | |
| DK3463328T3 (da) | Seladelpar til behandling af primær biliær cholangitis | |
| DE112015002989A5 (de) | Verfahren zur Desodorierung von Lignin | |
| DK3359170T3 (da) | Fremgangsmåder til behandling af nuklear faktor kappa-letkæde-enhancer af aktiveret b-celle-(nf-kb)-dysregulering hos en vært med behov derfor ved hjælp af æggeskalsmembransammensætninger | |
| DK3430072T3 (da) | Fremgangsmåde til oprensning af poloxamerer | |
| DK3347106T3 (da) | Modificering af naturfjer til anvendelse i sportsartikler |